Skip to main content

Together we are beating cancer

Donate now

Cancer News

In depth

Showing 12 out of 199 results
Antibody

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

by Cancer Research UK | In depth | 12 December 2023

12 December 2023

After a peer-review suggested the generation of more data, Dr Philip Dunne’s project on colorectal phenotypes faced calamity. Here's how FAIR data saved the day... After a peer-review suggested the generation of more data, Dr Philip Dunne’s project on colorectal phenotypes faced calamity. Here's how FAIR data saved the day...

by Cancer Research UK | In depth | 27 November 2023

27 November 2023

A GP examining a patient.

Why do some cancers, and some groups of people, tend to be diagnosed later? Here's our investigation into inequalities in early diagnosis. Why do some cancers, and some groups of people, tend to be diagnosed later? Here's our investigation into inequalities in early diagnosis.

by Hope Walters | In depth | 23 November 2023

23 November 2023

This entry is part 5 of 5 in the series Health inequalities
%postcontent%
Two cancer researchers looking at a cell image on screen

Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs. Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs.

by Cancer Research UK | In depth | 21 November 2023

21 November 2023

Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Science & Technology
  • Health & Medicine

10 ways we’ve influenced progress in lung cancer

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer.

by Amy Warnock | In depth | 1 November 2023

1 November 2023

Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important… Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important…

by Cancer Research UK | In depth | 30 October 2023

30 October 2023

Two multidisciplinary teams are investigating the potential of infrared technologies in cancer detection. We find out how they are applying lessons from diverse fields to detect cancer earlier.   Two multidisciplinary teams are investigating the potential of infrared technologies in cancer detection. We find out how they are applying lessons from diverse fields to detect cancer earlier.  

by Cancer Research UK | In depth | 25 October 2023

25 October 2023

Cancer cells with extrachromosomal DNA (ecDNA)

Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous. Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous.

by Tim Gunn | In depth | 23 October 2023

23 October 2023

An array of normal and cancerous human tissue samples.

Research suggests that artificial intelligence could be used alongside doctors to diagnose cancers faster, easing pressure on the cancer workforce. First, though, the NHS needs to get ready. Research suggests that artificial intelligence could be used alongside doctors to diagnose cancers faster, easing pressure on the cancer workforce. First, though, the NHS needs to get ready.

by Tom Hildebrand | In depth | 19 October 2023

19 October 2023

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li-Fraumeni syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li-Fraumeni syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023